Biocorp Production (FRA:8BP) ROCE % : 69.71% (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Biocorp Production ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biocorp Production's annualized ROCE % for the quarter that ended in Dec. 2022 was 69.71%.

Biocorp Production ROCE % Historical Data

The historical data trend for Biocorp Production's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocorp Production ROCE % Chart

Biocorp Production Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-176.03

21.08

-20.64

2.32

-13.54

Biocorp Production Semi-Annual Data
	Dec12	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
ROCE %	Get a 7-Day Free Trial														-22.87	-36.49	46.19	-87.34	69.71

Biocorp Production ROCE % Calculation

Biocorp Production's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-0.848	/	( ( (10.654 - 3.334)	+	(12.584 - 7.382) )	/ 2 )
	=	-0.848	/	( (7.32	+	5.202)	/ 2 )
	=	-0.848	/	6.261
	=	-13.54 %

Biocorp Production's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Jun. 2022 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Jun. 2022 )		(Q: Dec. 2022 )
	=	3.05	/	( ( (9.155 - 5.607)	+	(12.584 - 7.382) )	/ 2 )
	=	3.05	/	( ( 3.548	+	5.202 )	/ 2 )
	=	3.05	/	4.375
	=	69.71 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

Biocorp Production (FRA:8BP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biocorp Production ROCE % Related Terms

Thank you for viewing the detailed overview of Biocorp Production's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocorp Production (FRA:8BP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biocorp Production SA (FRA:8BP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Technological Park Lavaur la Bechade, Issoire, FRA, 63500

Website

http://www.biocorp.fr

Biocorp Production SA is engaged in the development, production, and marketing of medical devices and drug delivery systems for the pharmaceutical industry.

Biocorp Production (FRA:8BP) Headlines

No Headlines